In a transgenic mice model, restricting the expression of BCR-ABL in stem cell antigen 1 (Sca1)-positive cells, the authors generated a murine CML intrinsically resistant to IM [62]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.